The table below shows BIOGEN INC.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$645.50M
$259.30M
$553.20M
$455.30M
$161.80M
$769.00M
Capital expenditure
$51.20M
$37.10M
$45.90M
$66.60M
$57.90M
$92.60M
Investing cash flow
-$209.50M
-$47.30M
-$66.00M
-$953.00M
-$648.00M
-$64.70M
Dividends paid
-
-
-
-
BIIB operating cash flow (10-K history)
BIOGEN INC. reported operating cash flow of $2.20B for fiscal year 2025. That is down 23.3% from $2.88B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from $4.59B (FY 2016) to $2.20B. Figures come from the company's audited annual reports as filed with the SEC.
